Roschkov Sylvia, Rebeyka Darlene, Mah Jean, Urquhart Gayle
Metabolic Centre, University of Alberta Hospital, 8440-112 Street, Edmonton, Alberta, Canada.
Prog Cardiovasc Nurs. 2007 Winter;22(1):27-30. doi: 10.1111/j.0889-7204.2007.05884.x.
A variety of cardiac tumors have been acknowledged in the literature since the 16th century as rare forms of cardiac disease. Of the primary tumors, myxomas account for at least 30% to 50% of benign tumors. Despite significant advances in cardiac diagnostics leading to early recognition of myxomas, the potential for deleterious effects secondary to embolic complications remains high. The purpose of this paper is to provide nurses with an understanding of the epidemiology, pathology, clinical presentation, and assessment of individuals with cardiac myxomas. A case presentation is used to illustrate how the misdiagnosis of cardiac myxoma led to a delay in patient treatment. Prompt recognition, diagnosis, and treatment are important in improving patient outcomes and quality of life. Due to the infrequency of cardiac myxomas, ensuring appropriate preoperative and postoperative nursing care to the patient with a cardiac myxoma is essential.
自16世纪以来,文献中已承认多种心脏肿瘤是心脏病的罕见形式。在原发性肿瘤中,黏液瘤占良性肿瘤的至少30%至50%。尽管心脏诊断技术取得了重大进展,能够早期识别黏液瘤,但栓塞并发症继发的有害影响风险仍然很高。本文旨在让护士了解心脏黏液瘤患者的流行病学、病理学、临床表现和评估。通过一个病例介绍来说明心脏黏液瘤的误诊是如何导致患者治疗延误的。及时识别、诊断和治疗对于改善患者预后和生活质量至关重要。由于心脏黏液瘤发病率低,为心脏黏液瘤患者提供适当的术前和术后护理至关重要。